Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Pharmaceutical treatment process using chitosan or derivative thereof
Efficient paging in a wireless communication system
Semiconductor device
Method, system, and computer program product for scoring theoretical peptides
Method and system for security authentication of radio frequency identification
Control strategies for a multi-mode drive system
Method for identifying modulators of GPCR GPR1 function
  Randomly Featured Patents
Insulation displacement system
Fused thiophenes, articles, and methods thereof
Method and apparatus for producing underground pipes
Method for manufacturing semiconductor device including heat treating with a flash lamp
Reclaiming existing fields in address translation data structures to extend control over memory accesses
Observer tracking directional display and observer tracking illumination system
Production method of polymer film
Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof